Primary |
Product Used For Unknown Indication |
76.8% |
Hypertonic Bladder |
9.5% |
Pollakiuria |
2.5% |
Urinary Incontinence |
1.9% |
Micturition Urgency |
1.4% |
Incontinence |
1.2% |
Hypertension |
1.1% |
Urge Incontinence |
0.8% |
Nocturia |
0.8% |
Blood Pressure |
0.6% |
Bladder Disorder |
0.5% |
Cardiac Disorder |
0.5% |
Diabetes Mellitus |
0.5% |
Pain |
0.5% |
Blood Cholesterol |
0.4% |
Anxiety |
0.2% |
Asthma |
0.2% |
Cystitis Interstitial |
0.2% |
Insomnia |
0.2% |
Sleep Disorder |
0.2% |
|
Drug Ineffective |
27.5% |
Blood Pressure Increased |
8.8% |
Hypertension |
6.3% |
Intentional Drug Misuse |
6.1% |
Headache |
4.9% |
Urinary Retention |
4.9% |
Off Label Use |
4.0% |
Rash |
3.7% |
Dizziness |
3.5% |
Nocturia |
3.3% |
Rhinorrhoea |
3.3% |
Urticaria |
3.2% |
Constipation |
3.0% |
Urinary Tract Infection |
3.0% |
Palpitations |
2.6% |
Somnolence |
2.6% |
Pruritus |
2.5% |
Vision Blurred |
2.5% |
Dry Mouth |
2.1% |
Insomnia |
2.1% |
|
Secondary |
Product Used For Unknown Indication |
59.5% |
Hypertonic Bladder |
13.3% |
Pollakiuria |
5.7% |
Micturition Urgency |
4.8% |
Urinary Incontinence |
3.3% |
Incontinence |
2.2% |
Urge Incontinence |
2.0% |
Nocturia |
1.8% |
Hypertension |
1.3% |
Cardiac Disorder |
0.9% |
Gastrooesophageal Reflux Disease |
0.9% |
Blood Pressure |
0.8% |
Pain |
0.6% |
Bladder Spasm |
0.5% |
Blood Cholesterol |
0.5% |
Cystitis Interstitial |
0.5% |
Anxiety |
0.4% |
Arthritis |
0.4% |
Bladder Disorder |
0.4% |
Blood Pressure Increased |
0.4% |
|
Drug Ineffective |
30.4% |
Off Label Use |
7.6% |
Inappropriate Schedule Of Drug Administration |
6.3% |
Urinary Retention |
6.3% |
Blood Pressure Increased |
5.7% |
Headache |
5.1% |
Rhinorrhoea |
4.4% |
Muscle Spasms |
3.2% |
Vision Blurred |
3.2% |
Vomiting |
3.2% |
Drug Ineffective For Unapproved Indication |
2.5% |
Intentional Drug Misuse |
2.5% |
Nocturia |
2.5% |
Pruritus |
2.5% |
Rash |
2.5% |
Somnolence |
2.5% |
Swollen Tongue |
2.5% |
Urine Output Decreased |
2.5% |
Wrong Technique In Drug Usage Process |
2.5% |
Cerebrovascular Accident |
1.9% |
|
Concomitant |
Product Used For Unknown Indication |
46.2% |
Multiple Sclerosis |
5.8% |
Bladder Disorder |
4.6% |
Micturition Urgency |
4.6% |
Memory Impairment |
4.2% |
Blood Pressure |
3.8% |
Hypertension |
3.8% |
Depression |
2.7% |
Hypertonic Bladder |
2.7% |
Gastrooesophageal Reflux Disease |
2.3% |
Pain |
2.3% |
Pollakiuria |
2.3% |
Prostatic Disorder |
2.3% |
Urge Incontinence |
2.3% |
Premedication |
1.9% |
Urinary Incontinence |
1.9% |
Blood Cholesterol |
1.5% |
Blood Cholesterol Increased |
1.5% |
Diabetes Mellitus |
1.5% |
Incontinence |
1.5% |
|
Drug Ineffective |
11.1% |
Dysarthria |
11.1% |
Blood Glucose Increased |
7.4% |
Tremor |
7.4% |
Urinary Incontinence |
7.4% |
Constipation |
3.7% |
Dyspnoea |
3.7% |
Fatigue |
3.7% |
Lung Infection |
3.7% |
Mental Disorder |
3.7% |
Muscle Spasms |
3.7% |
Myelodysplastic Syndrome |
3.7% |
Myocardial Infarction |
3.7% |
No Adverse Event |
3.7% |
Pain |
3.7% |
Pain In Extremity |
3.7% |
Paraesthesia |
3.7% |
Parkinson's Disease |
3.7% |
Poor Venous Access |
3.7% |
Protein Urine Present |
3.7% |
|
Interacting |
Product Used For Unknown Indication |
70.3% |
Hypertonic Bladder |
10.8% |
Micturition Urgency |
8.1% |
Pollakiuria |
5.4% |
Hypothyroidism |
2.7% |
Convulsion |
1.4% |
Cystitis Interstitial |
1.4% |
|
Medical Device Implantation |
30.8% |
Drug Ineffective |
15.4% |
International Normalised Ratio Abnormal |
15.4% |
Nervousness |
15.4% |
Nasal Congestion |
7.7% |
Off Label Use |
7.7% |
Weight Decreased |
7.7% |
|